Advertisement FDA approves Cheetah Medical's cardiac monitor - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

FDA approves Cheetah Medical’s cardiac monitor

Cheetah Medical has reported that the FDA has approved for marketing the Reliant, a highly accurate, portable cardiac output monitor which provides a noninvasive window to cardiac and hemodynamic function.

The Reliant monitor is powered by Cheetah’s unique, patented Bioreactance technology, which has been used effectively in over 1,000 patients in various clinical settings including hemodynamic monitoring, heart failure, perioperative care, hemodialysis and stress testing.

Laura Rector, general manager at Cheetah Medical, said: “We believe that with Reliant, healthcare professionals see a device that can deliver a new standard of care.